What is the recommended treatment for sodium replacement in patients with hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sodium Replacement in Hyponatremia

The recommended treatment for sodium replacement in hyponatremia should be tailored based on symptom severity, acuity of onset, and volume status, with hypertonic saline (3%) reserved for severe symptomatic cases and a correction rate not exceeding 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome. 1

Assessment of Hyponatremia

Before initiating treatment, determine:

  • Symptom severity:

    • Severe symptoms: Mental status changes, seizures, coma 1
    • Mild symptoms: Nausea, vomiting, headache, weakness 2
    • Asymptomatic: No clinical manifestations 1
  • Volume status:

    • Hypovolemic: Signs of dehydration, orthostatic hypotension 3
    • Euvolemic: No signs of volume depletion or overload 3
    • Hypervolemic: Edema, ascites (common in cirrhosis) 1
  • Duration:

    • Acute: <48 hours 1
    • Chronic: >48 hours 1

Treatment Algorithm

1. Severe Symptomatic Hyponatremia (Mental status changes, seizures)

  • Administer 3% hypertonic saline: 1

    • Initial goal: Correct 6 mmol/L over 6 hours or until severe symptoms resolve
    • Total correction should not exceed 8 mmol/L in 24 hours
    • Calculate sodium deficit: Desired increase in Na (mEq) × (0.5 × ideal body weight)
    • Monitor serum sodium every 2 hours in ICU setting
  • Correction rate: 1

    • If 6 mmol/L is corrected in first 6 hours, limit further correction to 2 mmol/L in the following 18 hours
    • Rapid correction >1 mmol/L/hour should only be used for severely symptomatic and/or acute hyponatremia
  • After symptom improvement: 1

    • Transition to treatment for mild symptoms or asymptomatic protocol
    • Continue monitoring serum sodium levels closely

2. Mild Symptomatic Hyponatremia

  • For SIADH: 1

    • Fluid restriction to 1 L/day
    • Monitor sodium every 4 hours initially
    • If no response: Add oral sodium chloride 100 mEq TID
    • Consider high protein diet
  • For Hypovolemic Hyponatremia: 1, 2

    • Normal saline infusion to expand plasma volume
    • Correct underlying cause of volume depletion
  • For Hypervolemic Hyponatremia (e.g., cirrhosis): 1

    • Fluid restriction to 1-1.5 L/day for severe hyponatremia (Na <125 mmol/L)
    • Discontinue diuretics if they're contributing to hyponatremia
    • Reserve hypertonic saline for severely symptomatic patients only

3. Chronic Asymptomatic Hyponatremia

  • Avoid rapid correction: 1

    • Chronic hyponatremia should be corrected slowly to prevent osmotic demyelination syndrome
    • Target correction rate <8 mmol/L per 24 hours
  • Treat underlying cause: 3

    • SIADH: Fluid restriction, salt tablets, or vaptans in select cases
    • Cirrhosis: Fluid restriction, albumin in specific scenarios
    • Medication-induced: Adjust or discontinue causative medications

Special Considerations

Cirrhosis with Hyponatremia

  • Hypovolemic hyponatremia: 1

    • Requires plasma volume expansion with normal saline
    • Correct causative factors
  • Hypervolemic hyponatremia: 1

    • Fluid restriction to 1-1.5 L/day for severe hyponatremia (Na <125 mmol/L)
    • Hypertonic saline should be limited to severely symptomatic cases or pre-liver transplant patients
    • After initial correction (5 mmol/L in first hour for severe symptoms), limit to <8 mmol/L per day

Neurosurgical Patients

  • For Cerebral Salt Wasting (CSW): 1

    • Treatment with hypertonic saline and fludrocortisone for severe symptoms
    • Avoid fluid restriction which can worsen outcomes in subarachnoid hemorrhage patients
  • For SIADH in neurosurgical setting: 1

    • Primary treatment is fluid restriction unless severely symptomatic
    • Hypertonic saline for severe symptoms or subarachnoid hemorrhage patients at risk of vasospasm

Monitoring and Safety

  • Risk of overcorrection: 4

    • Higher in severely symptomatic patients (38% vs 6% in moderate symptoms)
    • Monitor diuresis closely as it correlates with sodium overcorrection
    • Consider reducing bolus volume and reevaluating before repeating infusions
  • Prevention of osmotic demyelination: 3, 2

    • Never exceed correction of 10 mmol/L in first 24 hours
    • For chronic hyponatremia, slower correction is safer
    • If overcorrection occurs, consider administering hypotonic fluids (D5W) to re-lower sodium levels
  • Oral sodium replacement option: 5

    • In selected cases where IV hypertonic saline is not feasible, hourly oral sodium chloride tablets may be considered
    • Calculate dose to deliver equivalent of 0.5 mL/kg/h of 3% NaCl
    • Requires very close monitoring of serum sodium levels

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.